Although research has aimed to determine the contributors to AD pathogenesis, including deposition of misfolded amyloid-β and tau, oxidative stress, inflammation, mitochondrial dysfunction, protein, and lipid dysregulation, such investigations have not yet led to the development of effective disease-modifying intervention [3]. This evidence concerns the gene MAPT and Alzheimer disease.